Is Preoperative Transarterial Chemoembolization Needed for a Resectable Hepatocellular Carcinoma?
β Scribed by Gi-Hong Choi; Dong-Hyun Kim; Chang-Moo Kang; Kyung-Sik Kim; Jin-Sub Choi; Woo-Jung Lee; Byong-Ro Kim
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 216 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Hepatocellular carcinoma (HCC) is one of the most malignant cancers in the world. The effect of preoperative transarterial chemoembolization (TACE) for resectable HCC is still controversial and costβassociated treatments are unknown. ## Methods We retrospectively compar
Criteria to select patients with hepatocellular carcinoma (HCC) for liver transplantation (LT) are based on tumor size and number of nodules rather than on tumor biology. The present study was undertaken to assess the role of transarterial chemoembolization (TACE) in selecting patients with tumors s